The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Merck is rated a buy, with strong earnings growth, rising cash flow, and balance sheet strength supporting a bullish outlook. Keytruda's double-digit growth and margin expansion drive MRK's profits, ...

Gardasil China sales: Caroline Litchfield indicated, "we will not resume shipments to China through at least the end of this year," as channel inventories remain elevated and demand continues to be ...

Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Co., Inc. (NYSE:MRK) on July ...

$MRK insiders have traded $MRK stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales. Here’s a ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per share, ...

Merck (MRK) stock is sinking 10% after the company provided weaker-than-expected 2025 guidance amid weak sales of Gardasil, its HPV vaccine. Additionally, the huge drug maker withdrew its long-term ...

Ill health has forced the Slovenian head coach to step down, less than two months out from a pair of crucial World Cup 26 qualifiers. Long-serving Uzbekistan head coach Srecko Katanec has stepped down ...

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024, despite challenges with other products. Promising future developments include successful ...